Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
The Annals of Thoracic Surgery|July 26, 2005
Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgeryChristopher P Cannon, Shamir R Mehta, Sary F Aranki
Current Opinion in Cardiology|June 16, 2017
Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel diseaseAsim N Cheema, Shamir R Mehta, Subodh Verma, et al.
American Heart Journal|December 17, 2013
Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysisKevin R Bainey, Shamir R Mehta, Tony Lai, et al.
The Canadian Journal of Cardiology|September 4, 2017
Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysisMatthias Bossard, Shamir R Mehta, Robert C Welsh, et al.
The Canadian Journal of Cardiology|July 19, 2022
The Evolution of Anticoagulation for Percutaneous Coronary Intervention: A 40-Year JourneyKevin R Bainey, Guillaume Marquis-Gravel, Shamir R Mehta, et al.
American Heart Journal|December 17, 2008
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trialsSanjit S Jolly, Shoaib Amlani, Martial Hamon, et al.
Current Cardiology Reports|March 16, 2022
Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary InterventionMohammad Alkhalil, Vladimír Džavík, Deepak L Bhatt, et al.
American Heart Journal|April 15, 2026
Design and rational of the The PRACTICAL-HERO trial: a randomized trial of higher and lower doses of heparin vs placebo for elective diagnostic coronary angiographyShahar Lavi, Shirin Shadpour, Emma Allen, et al.
Current Opinion in Cardiology|June 30, 2017
P2Y12 receptor inhibitor resistance and coronary artery disease: a bench to bedside primer for cardiovascular specialistsDerek Y F So, Akshay Bagai, Uyen Tran, et al.
CJC Open|June 25, 2021
Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in CanadaMarie Lordkipanidzé, Guillaume Marquis-Gravel, Jean-François Tanguay, et al.
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
The Annals of Thoracic Surgery|July 26, 2005
Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgeryChristopher P Cannon, Shamir R Mehta, Sary F Aranki
Current Opinion in Cardiology|June 16, 2017
Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel diseaseAsim N Cheema, Shamir R Mehta, Subodh Verma, et al.
American Heart Journal|December 17, 2013
Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysisKevin R Bainey, Shamir R Mehta, Tony Lai, et al.
The Canadian Journal of Cardiology|September 4, 2017
Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysisMatthias Bossard, Shamir R Mehta, Robert C Welsh, et al.
The Canadian Journal of Cardiology|July 19, 2022
The Evolution of Anticoagulation for Percutaneous Coronary Intervention: A 40-Year JourneyKevin R Bainey, Guillaume Marquis-Gravel, Shamir R Mehta, et al.
American Heart Journal|December 17, 2008
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trialsSanjit S Jolly, Shoaib Amlani, Martial Hamon, et al.
Current Cardiology Reports|March 16, 2022
Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary InterventionMohammad Alkhalil, Vladimír Džavík, Deepak L Bhatt, et al.
American Heart Journal|April 15, 2026
Design and rational of the The PRACTICAL-HERO trial: a randomized trial of higher and lower doses of heparin vs placebo for elective diagnostic coronary angiographyShahar Lavi, Shirin Shadpour, Emma Allen, et al.
Current Opinion in Cardiology|June 30, 2017
P2Y12 receptor inhibitor resistance and coronary artery disease: a bench to bedside primer for cardiovascular specialistsDerek Y F So, Akshay Bagai, Uyen Tran, et al.
CJC Open|June 25, 2021
Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in CanadaMarie Lordkipanidzé, Guillaume Marquis-Gravel, Jean-François Tanguay, et al.
Pageof 22